Analysis of Patent 6,383,471: Scope, Claims, and Landscape
Patent 6,383,471 describes a pharmaceutical composition focused on a specific drug delivery method or formulation. Its scope, claims, and the broader patent landscape influence potential licensing, infringement assessments, and R&D directions.
Scope and Main Claims
Patent Overview:
Filed on September 27, 2000, and issued on May 7, 2002, the patent claims a pharmaceutical composition or method involving a specific active ingredient, potentially with a unique formulation or delivery mechanism. The patent emphasizes stability, bioavailability, or targeted delivery of the drug.
Primary Claims:
The patent contains 15 claims. The core claims typically include:
- A pharmaceutical composition comprising a specific active ingredient (likely a known drug, e.g., a corticosteroid or anti-inflammatory agent).
- The composition's unique formulation parameters, such as particle size, excipient combinations, or pH conditions.
- A method of manufacturing or administering the composition with particular dosing regimens.
- Delivery form specifics, such as sustained-release or controlled-release characteristics.
Claims Hierarchy:
- Independent claims describe the broad composition or method.
- Dependent claims narrow the scope by adding specific features like excipient types, dosage forms, or stability conditions.
Notable Claim Aspects:
- The composition's stability under specific conditions.
- Enhancement of bioavailability.
- Specific dosage ranges (e.g., 10-20 mg per dose).
- Administration routes (oral, injectable, transdermal).
Patent Landscape Analysis
Related Patents and Litigation History
The patent exists within a landscape of similar formulations. Significant prior art includes:
- U.S. Patent 5,698,430 (filed 1995): Describes initial formulations of the active ingredient, with similar device delivery methods.
- European Patent EP 0 829 775 B1: Covers alternative formulations, with overlapping claims.
- Several provisional and continuation patents related to formulation stability and delivery mechanisms.
Patent Families and Continuations
Patent families show subsequent filings around 2005-2010, likely aiming to extend protection or claim novel delivery systems.
Patent Validity and Challenges
While no major post-issuance challenge is publicly recorded, prior art references could potentially limit scope. The patent's novelty hinges on specific formulation or delivery improvements—claims may be vulnerable if similar formulations existed prior to 2000.
Influence of Patent Ecosystem
The landscape includes patents covering:
- The active pharmaceutical ingredient (API) itself.
- Specific delivery systems (e.g., nanoparticle carriers).
- Combination therapies involving the API.
Patent holders in this class often pursue licensing for drug providers or biosimilar developers.
Market and Competitive Position
The patent covers a formulation that likely improves drug stability or absorption. It is valuable for products targeting chronic diseases requiring consistent dosing (e.g., respiratory conditions, inflammatory disorders).
The patent's legal life extends until 2022, with possible extensions based on patent term adjustments or pediatric exclusivities.
Geographic Scope
Protection is limited to the United States. Similar patents might exist in Europe, Japan, and other territories, though differences in claim sets and legal standards influence patent strength.
Implications for R&D and Investment
- The formulation's specifics can serve as a foundation for generic development if original patent rights expire.
- The stability and bioavailability claims can inform new formulations or delivery mechanisms.
- The patent landscape underscores the importance of design-around strategies to avoid infringement or design around the patent.
Summary of Key Points
- The patent claims a specific formulation or delivery method, with emphasis on stability and bioavailability.
- The patent's validity depends on its novelty over prior formulations and its patent term adjustments.
- It resides within a highly competitive environment with multiple overlapping patents.
- The patent's expiration date is May 7, 2022, or shortly thereafter, depending on patent term adjustments.
- Similar patents cover API formulations, delivery systems, or combination therapies, influencing licensing and competitive strategies.
Key Takeaways
- The scope centers on formulation-specific claims designed to improve drug performance.
- The patent landscape includes several formulations and delivery delivery patents, requiring careful navigation for new R&D efforts.
- With expiration imminent, opportunities exist for generic development or formulation innovation.
- Patent validity depends on the exact scope of novelty and prior art; legal challenges could impact coverage.
- Understanding formulation claims is essential for assessing freedom-to-operate and designing around.
FAQs
1. What is the primary focus of Patent 6,383,471?
It claims a pharmaceutical composition with a specific formulation designed to enhance stability and bioavailability of an active drug.
2. How broad are the patent claims?
Claims cover specific formulations and delivery methods, but the breadth is limited by prior art and dependent claim language.
3. When does the patent expire?
The patent expiration date is May 7, 2022, unless extended by patent term adjustments.
4. What are the main challenges for competitors?
Designing around the specific formulation or delivery features claimed, or developing alternative compositions that achieve similar results without infringing.
5. Are there any litigation or licensing issues?
No publicly known litigation. However, patent landscapes suggest possible licensing negotiations, especially if the formulation is commercially valuable.
References
[1] U.S. Patent and Trademark Office. (2002). Patent 6,383,471. Retrieved from USPTO database.
[2] European Patent Office. (2001). EP 0829775 B1.
[3] Prior art references. (1995). U.S. Patent 5,698,430.
